Caption: Dr. Xin Du will be responsible for managing Actinium’s regulatory submissions, CMC efforts, interacting with regulatory agencies and developing the Company’s regulatory strategy as pertains to both Iomab-B, Actimab-A and all future progra
Credit: Actinium Pharmaceuticals, Inc.